Search the Newsreel

Sera Prognostics Inc (SERA) (Q2 2026) Earnings Call Highlights: Payer Momentum Builds with ...

Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers

SHANGHAI, Aug. 13, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com said today that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People's Court (Jinan City, China) that directed Angel's Chinese subsidiaries to stop using the masterForce biomechanics simulation …

Suraksha Diagnostic consolidated net profit rises 38.40% in the June 2026 quarter

Signet Industries standalone net profit rises 1066.67% in the June 2026 quarter

Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities" artificially inflated the company's financial results. The complaint claims millions in operating expenses were misclassified as capital expenditures, leading to a …

Cadence Design Systems, Inc. (CDNS) Stock Forecasts

Argus has lowered its target price for Cadence Design Systems, Inc. (CDNS) to $367.00. The report, published on August 12, 2026, identifies Cadence Design Systems as a provider of electronic design automation software, intellectual property, and system design and analysis products. The current price …

Magnum Mining & Exploration Corrects Director Antonio Vitor Junior's Share Acquisition Notice

Cognex CEO Matthew Moschner Executes Stock Option Exercises and Sells 28,562 Shares Under Rule 10b5-1 Plan

Cognex Corp CEO Matthew Moschner exercised stock options and sold 28,562 shares of common stock on August 11, 2026, under a Rule 10b5-1 trading plan. These transactions resulted in his direct beneficial ownership decreasing to 10,884 shares of Cognex Common Stock. The sales and …

Lucid Diagnostics (NASDAQ:LUCD) Issues Earnings Results, Misses Estimates By $0.04 EPS

Lucid Diagnostics (NASDAQ:LUCD) reported a Q2 loss of $0.08 per share, missing analyst estimates by $0.04, despite revenue of $1.47 million which slightly exceeded expectations. Shares rose 1.9% following the announcement but remain near their 12-month low. Insider buying was noted, with Director Dennis …

Earnings call transcript: Sera Prognostics misses Q2 2026 estimates as growth builds

Key Points Interested in Sera Prognostics, Inc.? Here are five stocks we like better. Revenue remained modest at $30,000 in Q2, up from $17,000 a year earlier, while the net loss widened to $9.1 million. Sera ended the quarter with $80.3 million in cash …

Sera Prognostics earnings missed by $0.03, revenue fell short of estimates

Signet (SIG) Stock Slides as Market Rises: Facts to Know Before You Trade

Signet (SIG) closed the most recent trading day at $92.53, moving -2.31% from the previous trading session. This move lagged the S&P 500's daily gain of 0.26%. Meanwhile, the Dow experienced a drop of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.54%. …

Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6

Quest Diagnostics (DGX) announced that it will maintain its quarterly dividend at $0.86 per share. This dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. The announcement was published on August 12, 2026, by MT Newswires.

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

DocuSign (DOCU) Stock Falls Amid Market Uptick: What Investors Need to Know

DocuSign (DOCU) closed at $58.10 in the latest trading session, marking a -2.09% move from the prior day. This move lagged the S&P 500's daily gain of 0.26%. At the same time, the Dow lost 0.04%, and the tech-heavy Nasdaq gained 0.54%. Shares of …

Align Technology (ALGN): Capital World Investors reports 5% beneficial stake

Capital World Investors, a division of Capital Research and Management Company, has reported a beneficial ownership of 3,571,496 shares of Align Technology, Inc. common stock, which represents 5.0% of the company's outstanding shares. The filing indicates that Capital World Investors holds sole voting power …

Brian Gephart Sells 12,479 Shares of Magnite (NASDAQ:MGNI) Stock

Brian Gephart, CAO of Magnite (NASDAQ:MGNI), sold 12,479 shares of the company's stock for approximately $308,000, reducing his direct holdings by over 10%. This comes as Magnite reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, with revenue up 11.3% year-over-year. …

Magnite (NASDAQ:MGNI) Director Paul Caine Sells 5,000 Shares of Stock

Magnite Director Paul Caine sold 5,000 shares of MGNI stock on August 10th at an average price of $24.35, totaling $121,750, reducing his stake by 3.08%. This transaction occurred under a Rule 10b5-1 plan. Magnite recently reported strong earnings, beating EPS and revenue estimates, …

Insider Selling: Magnite (NASDAQ:MGNI) Director Sells $241,600.00 in Stock

Magnite (NASDAQ:MGNI) director Rachel Lam sold 10,000 shares of the company's stock for a total of $241,600, reducing her ownership by 4.16%. This comes after Magnite reported a quarterly earnings beat and revenue increase, with analysts largely maintaining a "Moderate Buy" consensus rating and …

Magnite director Paul Caine disposes of $121,750 in shares

Magnite director Paul Caine sold 5,000 shares of common stock for $121,750 on August 10, 2026, under a pre-arranged trading plan, despite the stock's recent surge. Following the sale, Mr. Caine still holds 157,401 shares. The company recently reported strong Q2 2026 financial results, …

How Investors Are Reacting To Magnolia (MGY) Earnings, Dividend Hike, Buybacks and WildFire-Funded Debt Issuance

Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Misses Revenue Estimates

Lucid Diagnostics (LUCD) Releases Q2 2026 Earnings: Revenue Up 26.7% but Losses Continue

Lucid Diagnostics (LUCD) reported a 26.7% increase in Q2 2026 revenue, reaching $1.5 million, which slightly exceeded analyst expectations. Despite this top-line growth, the company continued to post significant losses, with a net loss of $14.7 million. Insider trading activity shows one purchase in …

Signet Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Magnite (MGNI) director Rachel Lam sells 10,000 shares at $24.16 average

Magnite (MGNI) director Rachel Lam sold 10,000 shares of common stock on August 10, 2026, at a weighted average price of $24.16 per share, totaling approximately $241,600. Following this transaction, Lam directly holds 230,620 shares of MAGNITE common stock. The sale was a non-derivative …

Magnite (MGNI) Chief Accounting Officer sells 12,479 company shares

Magnite Inc.'s Chief Accounting Officer, Brian Gephart, sold 12,479 shares of company common stock on August 10, 2026. The transaction occurred in an open market or private sale at a weighted average price of $24.68 per share, totaling approximately $308,000. Following this sale, Gephart …

$LUCD Q2 '26 Earnings Results & Recap

Lucid Diagnostics (NASDAQ: LUCD) grows revenue but warns on going concern, debt load

Align Technology (ALGN) Gund-related holders report 5.4% beneficial stake

A group of trusts and individuals related to the Gund family have reported a collective beneficial ownership of 5.4% in Align Technology (ALGN), totaling 3,812,981 shares out of 71,039,852 outstanding shares as of July 31, 2026. Key figures in this group, G. Zachary Gund …

Sera Prognostics Reports Q2 Revenue of $30000 and $9.1 Million Net Loss

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026 to shareholders of record of Quest …

Quest Diagnostics Sets Oct. 21 Date for Cash Dividend

Quest Diagnostics (NYSE: DGX) has announced a quarterly cash dividend of $0.86 per share. The dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. This move reflects the company's commitment to providing direct cash returns to …

Sera Prognostics Q2 2026 Earnings: Commercial Progress Has Yet to Produce Material Revenue

Sera Prognostics (SERA) deepens Q2 2026 loss but extends cash runway to 2029

Lucid Diagnostics 2026: Revenue $1.47M, EPS ($0.08) — 10-Q Summary

Lucid Diagnostics Inc. reported its Q2 2026 financial results, showing revenue of $1.47 million and a net loss of ($14.72 million), resulting in a diluted loss per share of ($0.08). The company experienced increased EsoGuard test volume, expanded commercialization efforts, secured positive payer access …

Agnico Eagle Mines (AEM) sets $3.00 per Right contingent payout on Rupert deal

Agnico Eagle Mines (AEM) has established a Contingent Value Rights (CVR) Agreement in connection with its acquisition of Rupert Resources, authorizing up to 207,654,166 Rights. Each Right offers a potential payout of up to $3.00 in cash, distributed in three $1.00 tranches upon the …